Sudarshan Pharma Industries Past Earnings Performance
Past criteria checks 5/6
Sudarshan Pharma Industries has been growing earnings at an average annual rate of 37.3%, while the Chemicals industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 26.5% per year. Sudarshan Pharma Industries's return on equity is 10.3%, and it has net margins of 2.5%.
Key information
37.3%
Earnings growth rate
24.6%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 26.5% |
| Return on equity | 10.3% |
| Net Margin | 2.5% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Sudarshan Pharma Industries makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 4,635 | 115 | 48 | 0 |
| 31 Mar 23 | 4,613 | 70 | 42 | 0 |
| 31 Mar 22 | 3,571 | 52 | 31 | 0 |
| 31 Mar 21 | 1,935 | 27 | 20 | 0 |
| 31 Mar 20 | 1,480 | 13 | 23 | 0 |
| 31 Mar 19 | 1,391 | 23 | 49 | 0 |
| 31 Mar 18 | 881 | 7 | 43 | 0 |
| 31 Mar 17 | 554 | 2 | 23 | 0 |
| 31 Mar 16 | 379 | 1 | 14 | 0 |
Quality Earnings: 543828 has high quality earnings.
Growing Profit Margin: 543828's current net profit margins (2.5%) are higher than last year (1.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 543828's earnings have grown significantly by 37.3% per year over the past 5 years.
Accelerating Growth: 543828's earnings growth over the past year (62.8%) exceeds its 5-year average (37.3% per year).
Earnings vs Industry: 543828 earnings growth over the past year (62.8%) exceeded the Chemicals industry 10.9%.
Return on Equity
High ROE: 543828's Return on Equity (10.3%) is considered low.